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M.M.D. Lawrence-Brown1Departments of 1Vascular Surgery, and 2Radiology, Mount Hospital, Perth, WA, AustraliaIntroduction. The incidence of neurological injury following carotid angioplasty and stenting is of great interest to those
advocating it as an alternative to endarterectomy in the management of critical carotid stenosis. A significant inter-observer
variation exists in determining the presence or absence of a neurological deficit following the procedure objective imaging
would be advantageous. In this study, we sought to assess diffusion weighted MRI as a diagnostic tool in evaluating the
incidence of neurological injury following carotid angioplasty and stenting (CAS).
Patients and methods. The first 110 cases of CAS in our unit were included in this series. The procedure was abandoned in
three patients. Patients underwent intracranial and extracranial MR angiography, together with diffusion-weighted MRI
(DWI) prior to and following CAS and had a formal neurological assessment in the intensive care unit after the procedure.
Results. One hundred and ten Procedures were attempted in 98 patients. Twenty-eight percent were asymptomatic.
Following CAS, 7.2% of patients had a positive neurological exam (two major strokes with one fatality) and 21% had
positive DWI scans, equating to a sensitivity of 86% and a specificity of 85% for DWI in detecting cerebral infarction
following CAS. The positive predictive value of the test was 0.3 and negative predictive value 0.99. The major stroke and
death rate was 1.8%. While the use of a cerebral protection device appeared to significantly reduce the incidence of cerebral
infarction (5% vs. 25%, pZ0.031) this may be a reflection of the learning curve encountered during the study.
Conclusion. The incidence of subclinical DWI detected neurological injury was significantly higher than clinical
neurological deficit following CAS. Conventional methods of neurological assessment of patients undergoing CAS may be
too crude to detect subtle changes and more sensitive tests of cerebral function are required to establish whether these
subclinical lesions are relevant.Keywords: Carotid stenting; MRI scanning.Introduction
Carotid endarterectomy (CEA) is an effective method
of stroke prevention in certain selected populations.1–4
Developments in carotid angioplasty and stenting
(CAS) techniques in recent years have generated an
increasing interest in this procedure as it seeks to find
its’ place amongst the treatment options for critical
carotid stenosis. While the largest randomized trial of
carotid angioplasty published to date, the CAVATAS
trial, demonstrated equivalence between it and CEA,
the peri-procedural stroke rate of 10% was felt by
many to be excessive.5 Cerebral protection devices
(CPD) were not used during this study and less than
one-third of cases were stented following angioplasty,
steps which are now regarded as standard practice.ing author. C. McDonnell, MD, AFRCSI, Department of
gery, St James’s Hospital, James’s Street, Dublin 8,
: comcdonnell@eircom.net
0046 + 05 $35.00/0 q 2006 Elsevier Ltd. All rights reserAs such the findings of this trial have been largely
discounted.
Assessment of cerebral injury following carotid
stenting is of great interest to those promoting it as an
alternative to CEA. Clinical examination of the patient
may detect gross neurological changes, but more
complex methods such as cognitive testing6 are
necessary to detect more subtle cerebral injury. One
of the explanations offered for the high event rate seen
in the CAVATAS trial was that the patients were
examined by a neurologist rather than a vascular
surgeon to determine whether they had had a
neurological insult or not and thus it was more likely
that subtle changes which would have been missed by
vascular surgeons were picked up and labeled as
infarcts.5
Clearly some objective form of imaging is necessary
to resolve this issue. Computed tomography (CT)
scanning and standard T2 weighted magnetic reson-
ance imaging (MRI) will demonstrate infarct tissue butEur J Vasc Endovasc Surg 32, 46–50 (2006)
doi:10.1016/j.ejvs.2005.12.026, available online at http://www.sciencedirect.com onved.
Fig. 1. Cerebral infarct (arrowed) seen on DWI but not on standard T2 weighted MR.
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characteristics of recent and chronic stroke limit the
ability to determine the acuteness of an infarct.
Diffusion-weighted MR imaging (DWI) allows confi-
dent diagnosis of stroke when performed within 6–
7 days of the ictus and has been shown to be
approximately 98% accurate with some studies
finding 100% sensitivity and specificity7,8 (Fig. 1).
DWI evaluates changes in molecular movements
with normal diffusional motion, leading to signal loss. In
acutely ischaemic lesions diffusion is decreased. There-
fore, areas of acute ischaemia will have less signal loss
than normal areas leading to increased signal intensity
(SI) on DWI scans. Areas of chronic infarction have more
signal loss than normal areas and thus demonstrate
decreased SI on DWI. The abnormal SI declines
approximately 10–14 days after symptom onset.
The aim of this study was to review our experience
with magnetic resonance imaging in performing CAS
and to assess its usefulness in diagnosing cerebral
injury following carotid intervention.Patients and Methods
The first 110 carotid angioplasty and stent procedures
performed in 98 patients at our institution wereincluded in this study. Mean age was 68.7 years
(range 53–88) and 68% of patients were male. Twenty-
nine patients (26.3%) were asymptomatic but had
evidence of inadequate crossover circulation at the
level of the circle of Willis on a pre-procedural
intracranial MR angiogram (MRA). The procedures
were performed by a team of vascular surgeons and an
interventional radiologist with a special interest in
MR. Local ethical approval was obtained for this study
and patients provided informed consent before
entering the study.
The pre-procedural MRI protocol performed at our
institution consisted firstly of an extracranial MRA to
assess the aortic arch for abnormalities of vessel origin,
e.g. bovine-type arch or ostial stenosis, disease of the
arch itself which could be a potential source of
embolism, and the type of aortic arch (i.e. type I, II
or III). In addition, the extracranial MRA is also useful
in assessing vessel redundancy and the presence of a
distal tandem lesion, either of which could interfere
with the deployment of a cerebral protection device.
Secondly, an intracranial MRA with T1 and T2
weighted images, together with a DWI scan is
performed. The intracranial MRA allows for assess-
ment of cerebral crossover circulation as this influ-
enced the decision to intervene in patients with an
asymptomatic lesion. The MRA technique, which wasEur J Vasc Endovasc Surg Vol 32, July 2006
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imaging, which gave good resolution with minimal
artefact. The DWI scan is performed as a baseline to
exclude recent infarcts. In addition, apparent diffusion
coefficient (ADC) maps were obtained in order to
reduce the rate of false positives due to residual T2
weighting present in the imaging sequence (‘T2 shine-
through’). A post-procedural DWI scan was also
performed prior to discharge to look for new infarcts.
Most patients were discharged the day following the
procedure once the post-procedural DWI was
completed.
All symptomatic patients with greater than 70%,
and asymptomatic patients with a greater than 80%
internal carotid artery stenosis on duplex ultrasound
were considered for CAS. The presence of inadequate
crossover circulation at the level of the Circle of Willis
on the intracranial MRA, while not a prerequisite for
treatment, strengthened the case for intervening on
asymptomatic patients, as did the presence of silent
acute lesions on the pre-procedural DWI. Contra-
indications were the presence of a type III aortic arch,
extensive calcification at the level of stenosis or the
presence of a tortuous internal carotid artery distal to
the lesion, which would prevent the safe deployment
of a cerebral protection device.
Via a right groin puncture the common carotid was
catheterised using either a Hinck or Simmons catheter.
Using a wire exchange technique a Rosen or Amplatz
wire was placed in the ECA and a guide catheter
positioned in the distal CCA to act as a platform. The
lesion was then pre-dilated gently with a 3 mm
balloon if the surgeon and radiologist thought it
necessary and a cerebral protection device positioned
in the ICA distal to the lesion. The stent was then
deployed and post-dilated if the surgeon thought it
necessary. Completion arteriography was performed
and the patient returned to the intensive care unit for a
24 h period of monitoring. Following return to the ICU
the patients underwent separate neurological assess-
ment by both the intensive care consultant and the
vascular surgeon who performed the procedure. We
defined a ‘minor’ event as one resulting in no residual
neurological deficit after 30 days.
Statistical analysis was performed on a Dell
Latitude computer using Stats-Direct software. A p
value of less than 0.05 was taken to demonstrate
significance.Table 1. Comparison of neurological examination with DWI scans
following CAS
NeuroC NeuroK Total
DWIC 7 16 23
DWIK 1 86 87
Total 8 102 110Results
Three of the 110 procedures were abandoned, giving a
procedural success rate of 97.3%. Reasons forEur J Vasc Endovasc Surg Vol 32, July 2006abandonment were failure to cross the lesion in two
cases and total occlusion of the internal carotid artery
in the third. The two cases where the lesion could not
be traversed were subsequently managed successfully
with CEA.
Eight patients (7.2%) had positive neurological
findings following CAS. These manifested in six
patients as minor self-limiting deficits. Two patients
suffered a major disabling stroke, one of whom died,
giving a major stroke and death rate of 1.8%. In both
cases, the procedures were uneventful with normal
DWI scans and duplex images of the stent post-
operatively. The patient who died was non-compliant
with his clopidogrel medication, suffering in-stent
thrombosis 18 days post-procedure, leading to a fatal
stroke. The second patient suffered a stroke within
24 h of the procedure, duplex confirmed stent patency
with normal flow patterns. Following the procedure
this patient developed acute pulmonary oedema
secondary to congestive cardiac failure, which may
have contributed to the hypotensive middle cerebral
artery stroke. The presence or absence of symptoms
prior to intervention had no effect on the incidence of
either clinical, or subclinical DWI detected, neurologi-
cal injury.
Seven of the eight patients who had positive
findings on their post-operative neurological exam
had positive DWI scans while 16 patients had positive
DWIs despite being clinically asymptomatic (Table 1).
In total 23 patients (21%) had positive DWI scans
following the procedure, yielding a sensitivity of 85%
and specificity of 86% for DWI in detecting positive
neurological findings following CAS. The positive
predictive value of the test was 0.33 while the negative
predictive value was 0.99.
Use of a cerebral protection device was associated
with a significantly lower incidence of both clinical
and DWI-detected subclinical cerebral infarcts (Fig. 2).
The incidence of clinically detected stroke was 5% in
the protected group and 25% in the group who
underwent unprotected CAS (pZ0.031, Fisher’s exact
test). A similar finding applied to the incidence of
DWI-detected subclinical infarcts, with 18% of those
who had a CPD deployed having positive scans vs.
33% of the unprotected patients (pZ0.047, Fisher’s
exact test). However, all 12 of the patients who were
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Fig. 2. Incidence of DWI scan and neurological examination
positivity in patients stented with and without cerebral
protection. *p!0.031 protection vs. no protection (clinically
detected events), Fisher’s exact test. jp!0.047 protection vs.
no protection (DWI-detected events), Fisher’s exact test.
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the first half of the series and it is unclear whether the
higher infarct rate relates to the use of cerebral
protection or is merely a reflection of the learning
curve. The fact that the incidence of both DWI and
clinical neurological events is still higher in the earlier
half of the series even when the unprotected cases are
excluded suggests that it is the latter (Fig. 3). Several
CPDs were used, the Emboshield (Abbott Vascular,
Illinois USA) being by far the commonest. The number
of other devices used is too small to permit any useful
analysis of the efficacy of one device over the other.
Other complications following the procedure
included bradycardia and hypotension necessitating
pharmacological correction in nine cases (9%) and a
groin haematoma in one case (1%). It is the policy in
our unit not to give atropine prophylactically, and use
it only if bradycardia develops. Groin closure devices0
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Fig. 3. Incidence of DWI and clinically detected events with
unprotected cases removed from first half of series.are used routinely, as was the case in the patient who
developed a post-operative groin haematoma.Discussion
Magnetic resonance imaging serves many useful
purposes in planning a carotid stent. MR brain
imaging is of value in the patient who presents with
atypical symptoms in determining whether they have
had an infarct or not. MR angiography permits
assessment of the arch and access vessels for evidence
of ostial disease or abnormal arch anatomy, as well as
imaging the carotid lesion itself along with the distal
vessel, to assess for the presence of a tandem lesion or
vessel redundancy which could interfere with the
deployment of a cerebral protection device or the
carotid stent itself. The use of intracranial MRA allows
some assessment of the degree of crossover at the level
of the circle of Willis and may influence the decision to
stent or not if the patient is asymptomatic. All the
above information can be gleaned by use of standard
digital subtraction arteriography, but at the cost of a
1.8–2.3% periprocedural stroke rate. Finally, pre-
procedural MR scanning affords an opportunity to
obtain a diffusion-weighted scan for comparison with
post-operative images in order to determine whether
there have been any acute infarcts or not.
Although in our study the clinical neurological
event rate of 7.2% was in keeping with previously
reported series (CAVATAS), the subclinical injury rate
of 21%, as detected by DWI scanning, was significantly
higher. Jaeger and colleagues found DWI detected
infarcts in 22% of patients undergoing CAS.9 The
positive predictive value of 0.33 and negative pre-
dictive value of 0.99 suggests that either DWI is too
sensitive and identifies lesions that are not clinically
significant, or that standard neurological examination
is too crude to pick up the subtle changes associated
with these lesions and more complex tests of higher
cerebral function are necessary.6,10 Performing T2-
weighted MR at a later stage (3–6 months) to look for
areas of gliosis which match the pattern of emboli seen
on the immediate post-procedural DWI might provide
an answer to this issue.
One of the shortcomings of this study is the fact that
patients were not seen by a neurologist following their
procedure. Independent neurological review might
have picked up subtle changes associated with
cerebral injury which were missed by the vascular
surgeon and intensive care physician who assessed the
patients neurologically following CAS.
There is little doubt that small cerebral emboli,
such as those which occur as a consequence ofEur J Vasc Endovasc Surg Vol 32, July 2006
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ifesting as a gross neurological deficit, can cause
significant cognitive impairment.11 The same authors
noted an improvement in cognitive function following
CEA in patients with exhausted cerebral reserve.6 It
seems clear that in the light of the high incidence of
cerebral lesions detected in this study using DWI
scans, cognitive testing should be employed as a tool
of assessment of neurological injury following CAS.
While the use of cerebral protection devices during
CAS may appear intuitively obvious it is still a
controversial topic. Vos and colleagues found that
use of a CPD was associated with an increased risk of
microembolisation during all stages of CAS: crossing
the lesion with a wire, predilation, placement of the
protection device, stent deployment and post-
dilation.12 The primary aim of this study was not to
examine the efficacy of CPDs, therefore, our results to
suggest that the use of a cerebral protection device
reduces the incidence of both clinical and subclinical
cerebral injury must be interpreted with caution. Only
12 patients in this series were stented without cerebral
protection and these were all in the first half of the
series. Ahmadi suggests that 80 cases constitute the
learning curve or carotid stenting.13 Even though
the majority of neurological symptoms and DWI
positive scans occurred in the earlier group, we are
unable to say if this is due to the absence of a CPD, or
merely a reflection of the fact that these cases are on the
early part of the learning curve. The fact that exclusion
of the 12 stented patients from analysis still resulted in
a higher incidence of neurological lesions or events in
the earlier half of the series suggests that inexperience
may have been a key factor here. It may simply be the
case that the decision to introduce cerebral protection
during the lifetime of this study is itself a part of that
learning process. As such we can draw no further
conclusions from it.
To rigorously assess the relevance of DWI scanning
in carotid stenting, it will be necessary to compare the
results of post-operative scans to more sensitive tests
of higher cerebral function, such as tests of cognitive
impairment.Eur J Vasc Endovasc Surg Vol 32, July 2006References
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